Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Matter

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Chemmedchem|January 31, 2026
Nonstandard Factor VIIa Binding Mode Reveals S1 Pocket Plasticity in Trypsin-Like ProteasesLaura Tesmer, Hans Matter, Otmar Klingler, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibitionOtmar Klingler, Hans Matter, Manfred Schudok, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Design, synthesis, and structure-activity relationship of a new class of amidinophenylurea-based factor VIIa inhibitorsOtmar Klingler, Hans Matter, Manfred Schudok, et al.
Bioorganic & Medicinal Chemistry|September 6, 2002
Tetrahydroisoquinoline-3-carboxylate based matrix-metalloproteinase inhibitors: design, synthesis and structure-activity relationshipHans Matter, Manfred Schudok, Wilfried Schwab, et al.
Journal of Medicinal Chemistry|June 28, 2002
Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitorsHans Matter, Peter Kotsonis, Otmar Klingler, et al.
Angewandte Chemie (International Ed. in English)|December 23, 2011
Fragment deconstruction of small, potent factor Xa inhibitors: exploring the superadditivity energetics of fragment linking in protein-ligand complexesMarc Nazaré, Hans Matter, David W Will, et al.
Angewandte Chemie (International Ed. in English)|March 19, 2009
Evidence for C-Cl/C-Br...pi interactions as an important contribution to protein-ligand binding affinityHans Matter, Marc Nazaré, Stefan Güssregen, et al.
Chemmedchem|March 15, 2011
Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacyStefanie Keil, Hans Matter, Karl Schönafinger, et al.
Journal of Medicinal Chemistry|September 9, 2016
Discovery and Optimization of 1-Phenoxy-2-aminoindanes as Potent, Selective, and Orally Bioavailable Inhibitors of the Na<sup>+</sup>/H<sup>+</sup> Exchanger Type 3 (NHE3)Nils Rackelmann, Hans Matter, Heinrich Englert, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2013
Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimizationHans Matter, Gerhard Zoller, Andreas W Herling, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Chemmedchem|January 31, 2026
Nonstandard Factor VIIa Binding Mode Reveals S1 Pocket Plasticity in Trypsin-Like ProteasesLaura Tesmer, Hans Matter, Otmar Klingler, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibitionOtmar Klingler, Hans Matter, Manfred Schudok, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Design, synthesis, and structure-activity relationship of a new class of amidinophenylurea-based factor VIIa inhibitorsOtmar Klingler, Hans Matter, Manfred Schudok, et al.
Bioorganic & Medicinal Chemistry|September 6, 2002
Tetrahydroisoquinoline-3-carboxylate based matrix-metalloproteinase inhibitors: design, synthesis and structure-activity relationshipHans Matter, Manfred Schudok, Wilfried Schwab, et al.
Journal of Medicinal Chemistry|June 28, 2002
Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitorsHans Matter, Peter Kotsonis, Otmar Klingler, et al.
Angewandte Chemie (International Ed. in English)|December 23, 2011
Fragment deconstruction of small, potent factor Xa inhibitors: exploring the superadditivity energetics of fragment linking in protein-ligand complexesMarc Nazaré, Hans Matter, David W Will, et al.
Angewandte Chemie (International Ed. in English)|March 19, 2009
Evidence for C-Cl/C-Br...pi interactions as an important contribution to protein-ligand binding affinityHans Matter, Marc Nazaré, Stefan Güssregen, et al.
Chemmedchem|March 15, 2011
Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacyStefanie Keil, Hans Matter, Karl Schönafinger, et al.
Journal of Medicinal Chemistry|September 9, 2016
Discovery and Optimization of 1-Phenoxy-2-aminoindanes as Potent, Selective, and Orally Bioavailable Inhibitors of the Na<sup>+</sup>/H<sup>+</sup> Exchanger Type 3 (NHE3)Nils Rackelmann, Hans Matter, Heinrich Englert, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2013
Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimizationHans Matter, Gerhard Zoller, Andreas W Herling, et al.
Pageof 7